Impact of dihydrotestosterone on L-type calcium channels in human ventricular cardiomyocytes

Fikret Er1, Natig Gassanov, Mathias C Brandt

  • 1Department of Internal Medicine III, University of Cologne, 50937 Cologne, Germany.

Endocrine Research
|August 25, 2009
PubMed

Insights

Dihydrotestosterone increases calcium current in human heart cells by upregulating Ca(V)1.2 channels. This finding may explain cardiovascular effects seen in androgenic steroid abuse.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Endocrinology

Background:

  • Testosterone's cardiovascular effects are debated, with evidence for direct cardiac actions.
  • The impact of testosterone on human cardiac L-type calcium channels is unknown.
  • L-type calcium channels are crucial for cardiac electro-mechanical coupling.

Purpose of the Study:

  • To investigate the effect of dihydrotestosterone on human cardiac L-type calcium channels.
  • To determine if dihydrotestosterone influences the expression of Ca(V)1.2 subunits.

Main Methods:

  • Human ventricular myocytes were isolated from heart transplant patients.
  • Whole-cell patch-clamp electrophysiology was used to measure L-type calcium current (I(Ca,L)).
  • Dihydrotestosterone treatment was applied to cultured cardiomyocytes.

Main Results:

  • Dihydrotestosterone (100 nmol/L for 24-30h) significantly increased I(Ca,L) density in human ventricular myocytes.
  • The current-voltage relationship of I(Ca,L) remained unchanged.
  • Dihydrotestosterone treatment led to a 1.35-fold increase in Ca(V)1.2 subunit expression.

Conclusions:

  • Dihydrotestosterone enhances L-type calcium current density in human ventricular myocytes.
  • This effect is mediated by the upregulation of the Ca(V)1.2 channel subunit.
  • These findings offer a potential mechanism for the cardiovascular effects associated with androgenic steroid abuse.
Abstract

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Feedback Regulation of Calcium Concentration01:27

Feedback Regulation of Calcium Concentration

Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...